Diphenylpyraline

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33361OE3AV, chemically known as piperidine, 4- (diphenylmethoxy)-1-methyl-, hydrochloride but generally known as diphenylpyraline, which bears US NIH Compound Identifier 3103. European Medicines Agency schedules Diphenylpyraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07213MIG. The term DIPHENYLPYRALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules diphenylpyraline in its Anatomical Therapeutic Chemical (ATC) Classification. DIPHENYLPYRALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diphenylpyraline under HS 29333999 and SITC 51574. As of Q4 2014, DIPHENYLPYRALINE remains the US FDA Preferred Term for this commodity. Diphenylpyraline bears US NLM identifiers UMLS ID C0058389 and NCI Concept Code C65423. SMILES: O(C1CCN(CC1)C)C(C1CCCCC1)C1CCCCC1.